Since June 2019, the New Mexico Department of Health (NMDOH) has added a new qualifying condition to its medical marijuana program.
The New Mexico Department of Health (NMDOH) announced during a medical marijuana advisory board meeting on December 6th that it will add anxiety to the list of qualifying conditions for enrollment starting from January 1st, 2023.
According to a press release, a request to add anxiety disorder as a qualifying condition was submitted to the board for review in March, and was approved by Dr. David R. Scrase, Cabinet Secretary for the NMDOH, in November.
Scrase states in his decision that anxiety is a debilitating illness, and although patients can use adult-use cannabis without a medical card, by adding anxiety to the list of qualifying conditions, patients will have more opportunities to discuss with their health care providers how to use cannabis to alleviate their anxiety symptoms.
2FIRSTS will continue to monitor and report on this topic. Further updates will be available on the '2FIRSTS APP.' Scan the QR code below to download the app.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
